Major Depressive Disorder Drug Market Report

China Major Depressive Disorder Drug Industry Market Research Report 2023-2029

  • POSTDATE：Oct 07, 2023
  • PAGES：218
  • REPORT CODE：GMM1835409
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Major Depressive Disorder Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bristol-Myers Squibb Company

    • Intra-Cellular Therapies, Inc

    • F Hoffmann-La Roche Ltd

    • Eli Lilly and Company

    • e-Therapeutics Plc

    • Cerecor Inc

    • H Lundbeck A/S

    • GlaxoSmithKline Plc

    By Type:

    • Brexpiprazole

    • Others

    • AV-101

    • AVP-786

    • Aripiprazole

    • Basimglurant

    By Application:

    • Research Center

    • Hospital

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Major Depressive Disorder Drug Market Overview 2018-2029

    • 1.1 China Major Depressive Disorder Drug Industry Development Overview

    • 1.2 China Major Depressive Disorder Drug Industry Development History

    • 1.3 China Major Depressive Disorder Drug Industry Market Size (2018-2029)

    • 1.4 China Major Depressive Disorder Drug Market Analysis by Type from Production Side

      • 1.4.1 China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Brexpiprazole (2018-2029)

      • 1.4.2 China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of AV-101 (2018-2029)

      • 1.4.4 China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of AVP-786 (2018-2029)

      • 1.4.5 China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Aripiprazole (2018-2029)

      • 1.4.6 China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Basimglurant (2018-2029)

    • 1.5 China Major Depressive Disorder Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Major Depressive Disorder Drug Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

      • 1.5.2 China Major Depressive Disorder Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Major Depressive Disorder Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Major Depressive Disorder Drug Market Analysis by Region

      • 1.6.1 North China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Major Depressive Disorder Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Major Depressive Disorder Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Major Depressive Disorder Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Major Depressive Disorder Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Major Depressive Disorder Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Major Depressive Disorder Drug Industry Development

    Chapter 3 Major Depressive Disorder DrugIndustry Chain Analysis

    • 3.1 Major Depressive Disorder Drug Industry Chain

    • 3.2 Major Depressive Disorder Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Major Depressive Disorder Drug Market

    • 3.3 Major Depressive Disorder Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Major Depressive Disorder Drug Market

    Chapter 4 China Major Depressive Disorder Drug Market, by Type

    • 4.1 China Major Depressive Disorder Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Major Depressive Disorder Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Major Depressive Disorder Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Major Depressive Disorder Drug Production Volume and Growth Rate of Brexpiprazole

      • 4.5.2 China Major Depressive Disorder Drug Production Volume and Growth Rate of Others

      • 4.5.3 China Major Depressive Disorder Drug Production Volume and Growth Rate of AV-101

      • 4.5.4 China Major Depressive Disorder Drug Production Volume and Growth Rate of AVP-786

      • 4.5.5 China Major Depressive Disorder Drug Production Volume and Growth Rate of Aripiprazole

      • 4.5.6 China Major Depressive Disorder Drug Production Volume and Growth Rate of Basimglurant

    Chapter 5 China Major Depressive Disorder Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Major Depressive Disorder Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Major Depressive Disorder Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Major Depressive Disorder Drug Market Size and Growth Rate of Research Center

      • 5.5.2 China Major Depressive Disorder Drug Market Size and Growth Rate of Hospital

      • 5.5.3 China Major Depressive Disorder Drug Market Size and Growth Rate of Clinic

    Chapter 6 China Major Depressive Disorder Drug Market, by Region

    • 6.1 China Major Depressive Disorder Drug Production Volume and Production Value, by Region

    • 6.2 China Major Depressive Disorder Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Major Depressive Disorder Drug Market Analysis

    • 7.1 North China Major Depressive Disorder Drug Market, by Type

    • 7.2 North China Major Depressive Disorder Drug Market, by Application

    Chapter 8 Central China Major Depressive Disorder Drug Market Analysis

    • 8.1 Central China Major Depressive Disorder Drug Market, by Type

    • 8.2 Central China Major Depressive Disorder Drug Market, by Application

    Chapter 9 South China Major Depressive Disorder Drug Market Analysis

    • 9.1 South China Major Depressive Disorder Drug Market, by Type

    • 9.2 South China Major Depressive Disorder Drug Market, by Application

    Chapter 10 East China Major Depressive Disorder Drug Market Analysis

    • 10.1 East China Major Depressive Disorder Drug Market, by Type

    • 10.2 East China Major Depressive Disorder Drug Market, by Application

    Chapter 11 Northeast China Major Depressive Disorder Drug Market Analysis

    • 11.1 Northeast China Major Depressive Disorder Drug Market, by Type

    • 11.2 Northeast China Major Depressive Disorder Drug Market, by Application

    Chapter 12 Southwest China Major Depressive Disorder Drug Market Analysis

    • 12.1 Southwest China Major Depressive Disorder Drug Market, by Type

    • 12.2 Southwest China Major Depressive Disorder Drug Market, by Application

    Chapter 13 Northwest China Major Depressive Disorder Drug Market Analysis

    • 13.1 Northwest China Major Depressive Disorder Drug Market, by Type

    • 13.2 Northwest China Major Depressive Disorder Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bristol-Myers Squibb Company

        • 14.1.1 Bristol-Myers Squibb Company Company Profile

        • 14.1.2 Bristol-Myers Squibb Company Major Depressive Disorder Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Intra-Cellular Therapies, Inc

        • 14.2.1 Intra-Cellular Therapies, Inc Company Profile

        • 14.2.2 Intra-Cellular Therapies, Inc Major Depressive Disorder Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 F Hoffmann-La Roche Ltd

        • 14.3.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.3.2 F Hoffmann-La Roche Ltd Major Depressive Disorder Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eli Lilly and Company

        • 14.4.1 Eli Lilly and Company Company Profile

        • 14.4.2 Eli Lilly and Company Major Depressive Disorder Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 e-Therapeutics Plc

        • 14.5.1 e-Therapeutics Plc Company Profile

        • 14.5.2 e-Therapeutics Plc Major Depressive Disorder Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Cerecor Inc

        • 14.6.1 Cerecor Inc Company Profile

        • 14.6.2 Cerecor Inc Major Depressive Disorder Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 H Lundbeck A/S

        • 14.7.1 H Lundbeck A/S Company Profile

        • 14.7.2 H Lundbeck A/S Major Depressive Disorder Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 GlaxoSmithKline Plc

        • 14.8.1 GlaxoSmithKline Plc Company Profile

        • 14.8.2 GlaxoSmithKline Plc Major Depressive Disorder Drug Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Major Depressive Disorder Drug Industry Research Conclusions

    • 15.2 Major Depressive Disorder Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Major Depressive Disorder Drug Industry Market Size (2018-2029)

    • Figure China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Brexpiprazole (2018-2029)

    • Figure China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of AV-101 (2018-2029)

    • Figure China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of AVP-786 (2018-2029)

    • Figure China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Aripiprazole (2018-2029)

    • Figure China Major Depressive Disorder Drug Production Volume, Production Value and Growth Rate of Basimglurant (2018-2029)

    • Figure China Major Depressive Disorder Drug Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

    • Figure China Major Depressive Disorder Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Major Depressive Disorder Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Major Depressive Disorder Drug Market Size and Growth Rate from 2018-2029

    • Figure Major Depressive Disorder Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Major Depressive Disorder Drug Market Share by Type in 2018

    • Figure China Major Depressive Disorder Drug Market Share by Type in 2023

    • Figure China Major Depressive Disorder Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume and Growth Rate of Brexpiprazole (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume and Growth Rate of AV-101 (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume and Growth Rate of AVP-786 (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume and Growth Rate of Aripiprazole (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume and Growth Rate of Basimglurant (2018-2023)

    • Figure China Major Depressive Disorder Drug Market Share by Application in 2018

    • Figure China Major Depressive Disorder Drug Market Share by Application in 2023

    • Figure China Major Depressive Disorder Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Major Depressive Disorder Drug Market Size and Growth Rate of Research Center (2018-2023)

    • Figure China Major Depressive Disorder Drug Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Major Depressive Disorder Drug Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Major Depressive Disorder Drug Production Volume by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Production Volume Share by Region (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Volume Share by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Production Value by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Production Value Share by Region (2018-2023)

    • Figure China Major Depressive Disorder Drug Production Value Share by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Sales Volume by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Sales Volume Share by Region (2018-2023)

    • Figure China Major Depressive Disorder Drug Sales Volume Share by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Sales Value by Region (2018-2023)

    • Table China Major Depressive Disorder Drug Sales Value Share by Region (2018-2023)

    • Figure China Major Depressive Disorder Drug Sales Value Share by Region (2018-2023)

    • Table North China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table North China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure North China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table North China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table North China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table Central China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table Central China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table Central China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table South China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table South China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure South China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table South China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table South China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table East China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table East China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure East China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table East China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table East China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table Northeast China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table Southwest China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Major Depressive Disorder Drug Production Volume by Type (2018-2023)

    • Table Northwest China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Major Depressive Disorder Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Major Depressive Disorder Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Major Depressive Disorder Drug Sales Volume Share by Application (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table Intra-Cellular Therapies, Inc Company Profile

    • Table Intra-Cellular Therapies, Inc Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table e-Therapeutics Plc Company Profile

    • Table e-Therapeutics Plc Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table Cerecor Inc Company Profile

    • Table Cerecor Inc Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table H Lundbeck A/S Company Profile

    • Table H Lundbeck A/S Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc Company Profile

    • Table GlaxoSmithKline Plc Major Depressive Disorder Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US